https://www.selleckchem.com/pr....oducts/as2863619.htm
Background Despite the divergent disease biology of cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC), waitlist prioritization is identical for both diagnoses. Methods We compared waitlist and post-transplant outcomes between CCA and HCC liver transplant patients with MELD exceptions using Scientific Registry of Transplant Recipients data. 408 CCA candidates listed between 2003 and mid-2017 were matched to two HCC cohorts by listing date (±2 months, n=816), and OPTN region and date (±6 months, n=408). Cumulative incidence co
Like
Comment
Share
